Will FDA approved phentolamine ophthalmic solution 0.75% eye drops impact pediatric care?
September 28th 2023In this Contemporary Pediatrics® interview, Rupa Wong, MD, discusses the recent FDA approval of phentolamine ophthalmic solution 0.75% eye drops to treat pharmacologically-induced mydriasis, and how this could impact the treatment landscape for the pediatric population. [Editor's note: RYZUMVI was previously known as Nyxol, which is referenced in the interview.]
2 Clarke Drive
Cranbury, NJ 08512